CHDS faculty Stephen Resch and Lisa A. Robinson participated in a symposium focused on updating and refining the understanding of the economic impact of HIV in low resource settings. The meeting was convened by the Bill & Melinda Gates Foundation in Cascais, Portugal, and included a small group of top scholars, policy makers, and donors.
The symposium explored the value to recipient countries of financing the HIV response from domestic sources, taking into consideration the expected level of donor funding, the economic impact of the disease and of its control, and the wellbeing of the population. Participants discussed the best evidence available on the fiscal, human capital, and economic growth impacts of HIV and the response, with a goal to develop a generalizable framework to guide analysis and policy at the country level. Specifically, Ms. Robinson addressed the value of mortality risk reductions within a full income framework, and Dr. Resch compared the impacts of HIV treatment and prevention with the impacts of addressing other health conditions. The framework that results from the meeting will be the basis for discussions with finance ministers and advisors.
Explore Bill & Melinda Gates Foundation grants led by Stephen Resch and Lisa A. Robinson:
Led by Stephen Resch (PI), explore the EPIC Immunization Costing project, a multi-year initiative that launched with primary data collection in 6 countries, working to improve the availability and quality of immunization cost and financing information for low-income countries.
Led by Lisa Robinson (PI) and James Hammitt (Co-PI), explore the Guidelines for Benefit-Cost Analysis project, which aims to develop guidelines for rigorous benefit‐cost analyses. These guidelines will provide a reference case to promote comparability across analyses, and include principles, methodological specifications, and reporting standards.
Related news: Immunization Delivery Catalogue
Related news: Prevalence of TB in U.S.